Overview and Scope
Prenatal testing and newborn screening tests are diagnostic tests to detect any possible birth defects that may be there in the baby. These are useful in determining the health of the baby.
Sizing and Forecast
The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $5.52 billion in 2023 to $6.2 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to advancements in genetic testing, increased maternal age, awareness and education, healthcare policy and regulations.
The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $9.76 billion in 2028 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to genetic counseling, technological advancements, point-of-care testing, telehealth and remote monitoring. Major trends in the forecast period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies and sickle cell screening.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report
Segmentation & Regional Insights
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers
North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
Major Driver Impacting Market Growth
The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing & newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anaemia, Haemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anaemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in November 2021, according to the National Center for Biotechnology Information, a US-based medical organization, genetic illnesses were detected in 9.4% of pediatric patients, and among these patients, 44.7% were critically ill newborns. The high prevalence of genetic diseases in infants boosted the demand for growth of the prenatal testing and newborn screening market.
Key Industry Players
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.
The prenatal testing & newborn screening market report table of contents includes:
1. Executive Summary
2. Prenatal Testing & Newborn Screening Market Characteristics
3.Prenatal Testing & Newborn Screening Market Trends And Strategies
4.Prenatal Testing & Newborn Screening Market analysis
5.Prenatal Testing & Newborn Screening Market Size And Growth
6.Prenatal Testing & Newborn Screening Segmentation
7.Prenatal Testing & Newborn Screening Regional And Country Analysis
.
.
.
27.Prenatal Testing & Newborn Screening Competitive Landscape And Company Profiles
28.Prenatal Testing & Newborn Screening Key Mergers And Acquisitions
29.Prenatal Testing & Newborn Screening Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- PerkinElmer Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Natera Inc.
- Invitae Corporation
- Centogene AG
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
